Cytokines tumor necrosis factor and interleukin‐6 in experimental biliary obstruction in mice
暂无分享,去创建一个
D. Gouma | W. Buurman | J. Greve | M. Bemelmans | W. Buurman | D. J. Gouma | M. H. A. Bemelmans | J. W. Greve | W. A. Buurman | J. Greve
[1] G. Jackson,et al. High levels of secretory IgA and free secretory component in the serum of rats with bile duct obstruction , 1978, The Journal of experimental medicine.
[2] E. S. Fox,et al. Clearance of gut-derived endotoxins by the liver. Release and modification of 3H, 14C-lipopolysaccharide by isolated rat Kupffer cells. , 1989, Gastroenterology.
[3] A. Waage,et al. ASSOCIATION BETWEEN TUMOUR NECROSIS FACTOR IN SERUM AND FATAL OUTCOME IN PATIENTS WITH MENINGOCOCCAL DISEASE , 1987, The Lancet.
[4] S. Deventer,et al. Intestinal endotoxemia: Clinical significance , 1988 .
[5] W A Buurman,et al. Suppression of cellular immunity in obstructive jaundice is caused by endotoxins: a study with germ-free rats. , 1990, Gastroenterology.
[6] P. Ghezzi,et al. Dexamethasone Modulation of In Vivo Effects of Endotoxin, Tumor Necrosis Factor, and Interleukin‐1 on Liver Cytochrome P‐450, Plasma Fibrinogen, and Serum Iron , 1989, Journal of leukocyte biology.
[7] P. Lansdorp,et al. Production of hybridoma growth factor by human monocytes , 1987, European journal of immunology.
[8] L. Rikkers,et al. Biliary obstruction and host defense failure. , 1982, The Journal of surgical research.
[9] E. Wisse,et al. The role of bile acids in the development of endotoxemia during obstructive jaundice in the rat. , 1990, Journal of hepatology.
[10] J F Schlegel,et al. Endotoxemia after relief of biliary obstruction by internal and external drainage in rats. , 1986, American journal of surgery.
[11] J. Maessen,et al. Role of tumour necrosis factor in the enhanced sensitivity of mice to endotoxin after exposure to lead. , 1989, Immunopharmacology and immunotoxicology.
[12] K. Glaser,et al. Adaptation to bacterial lipopolysaccharide controls lipopolysaccharide-induced tumor necrosis factor production in rabbit macrophages. , 1990, The Journal of clinical investigation.
[13] E. Ribi,et al. Reaction of Endotoxin and Surfactants I. Physical and Biological Properties of Endotoxin Treated with Sodium Deoxycholate , 1966, Journal of bacteriology.
[14] B. Beutler,et al. Cachectin: more than a tumor necrosis factor. , 1987, The New England journal of medicine.
[15] M. Hansen,et al. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. , 1989, Journal of immunological methods.
[16] E. Ribi,et al. Reaction of endotoxin and surfactants. II. Immunologic properties of endotoxins treated with sodium deoxycholate. , 1968, Journal of immunology.
[17] M. Gore,et al. Tumour necrosis factor, cholestatic jaundice, and chronic liver disease. , 1990, Gut.
[18] W A Buurman,et al. Bile acids inhibit endotoxin‐induced release of tumor necrosis factor by monocytes: An in Vitro study , 1989, Hepatology.
[19] J. Pain,et al. Measurement of operative plasma endotoxin levels in jaundiced and non-jaundiced patients. , 1987, European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes.
[20] J. Nolan. Endotoxin, reticuloendothelial function, and liver injury , 1981, Hepatology.
[21] B. Beutler,et al. Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells , 1985, The Journal of experimental medicine.
[22] A. Kaplun,et al. Immune status in mice with experimental biliary obstruction. , 1980, Clinical immunology and immunopathology.
[23] M. Bailey. Endotoxin, bile salts and renal function in obstructive jaundice , 1976, The British journal of surgery.
[24] L. Bertók. Physico-Chemical Defense of Vertebrate Organisms: The Role of Bile Acids in Defense Against Bacterial Endotoxins , 2015, Perspectives in biology and medicine.
[25] W. Walker,et al. The Effect of Bile Duct Obstruction on the Clearance of Circulating IgA Immune Complexes , 1984, Hepatology.
[26] J. Shands,et al. The dispersion of gram-negative lipopolysaccharide by deoxycholate. Subunit molecular weight. , 1980, The Journal of biological chemistry.
[27] A. Forrest,et al. Letter: Procaine and malignant hyperthermia. , 1974, Lancet.
[28] S. Zuckerman,et al. Differential regulation of lipopolysaccharide‐induced interleukin 1 and tumor necrosis factor synthesis: effects of endogenous and exogenous glucocorticoids and the role of the pituitary‐adrenal axis , 1989, European journal of immunology.
[29] D. Gouma,et al. Prevention of Postoperative Complications in Jaundiced Rats: Internal Biliary Drainage Versus Oral Lactulose , 1990, Annals of surgery.
[30] R. Strieter,et al. In vivo dynamics of murine tumor necrosis factor-alpha gene expression. Kinetics of dexamethasone-induced suppression. , 1989, Laboratory investigation; a journal of technical methods and pathology.
[31] R. Schreiber,et al. Generation and characterization of hamster monoclonal antibodies that neutralize murine tumor necrosis factors. , 1989, Journal of immunology.
[32] J. Larrick,et al. Regulation of macrophage tumor necrosis factor production by prostaglandin E2. , 1986, Biochemical and biophysical research communications.